Related references
Note: Only part of the references are listed.Diphtheria Toxin-Epidermal Growth Factor Fusion Protein DAB389EGF for the Treatment of Bladder Cancer
Xiaoping Yang et al.
CLINICAL CANCER RESEARCH (2013)
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
Haoqiang Ying et al.
CELL (2012)
An NF-κB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice
Jaroslaw Daniluk et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice
Meredith A. Collins et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
BLADDER TUMOURS: TIME FOR A PARADIGM SHIFT?
Per-Uno Malmstrom
BJU INTERNATIONAL (2011)
beta-Catenin activation synergizes with PTEN loss to cause bladder cancer formation
I. Ahmad et al.
ONCOGENE (2011)
Substrate Elasticity Regulates Skeletal Muscle Stem Cell Self-Renewal in Culture
P. M. Gilbert et al.
SCIENCE (2010)
Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium
Peter J. Goebell et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2010)
Novel Targeted Agents for the Treatment of Bladder Cancer: Translating Laboratory Advances into Clinical Application
Xiaoping Yang et al.
INTERNATIONAL BRAZ J UROL (2010)
Mouse orthotopic models for bladder cancer research
Eddie Chan et al.
BJU INTERNATIONAL (2009)
Progressive Tumor Formation in Mice with Conditional Deletion of TGF-β Signaling in Head and Neck Epithelia Is Associated with Activation of the PI3K/Akt Pathway
Yansong Bian et al.
CANCER RESEARCH (2009)
Deficiency of pRb Family Proteins and p53 in Invasive Urothelial Tumorigenesis
Feng He et al.
CANCER RESEARCH (2009)
Rapamycin Prevents Early Onset of Tumorigenesis in an Oral-Specific K-ras and p53 Two-Hit Carcinogenesis Model
Ana R. Raimondi et al.
CANCER RESEARCH (2009)
Inactivation of p53 and Pten promotes invasive bladder cancer
Anna M. Puzio-Kuter et al.
GENES & DEVELOPMENT (2009)
Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase
Michel DuPage et al.
NATURE PROTOCOLS (2009)
Multiple functions encoded by the N-terminal PAT domain of adipophilin
David J. Orlicky et al.
JOURNAL OF CELL SCIENCE (2008)
Molecular origins of cancer: Lung cancer
Roy S. Herbst et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A spatially and temporally restricted mouse model of soft tissue sarcoma
David G. Kirsch et al.
NATURE MEDICINE (2007)
Maximizing mouse cancer models
Kristopher K. Frese et al.
NATURE REVIEWS CANCER (2007)
Clinical model of lifetime cost of treating bladder cancer and associated complications
Elenir B. C. Avritscher et al.
UROLOGY (2006)
Gene deletion in urothelium by specific expression of Cre recombinase
L Mo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Trp53R172H and KraSG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
SR Hingorani et al.
CANCER CELL (2005)
Endogenous oncogenic K-rasG12D stimulates proliferation and widespread neoplastic and developmental defects
DA Tuveson et al.
CANCER CELL (2004)
E1A and E1B proteins inhibit inflammation induced by adenovirus
J Schaack et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
p53 deficiency provokes urothelial proliferation and synergizes with activated Ha-ras in promoting urothelial tumorigenesis
J Gao et al.
ONCOGENE (2004)
Development of stable liquid formulations for adenovirus- based vaccines
RK Evans et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model
R Meuwissen et al.
CANCER CELL (2003)
Controlling gene expression in the urothelium using transgenic mice with inducible bladder specific Cre-Lox recombination
A Bex et al.
JOURNAL OF UROLOGY (2002)
Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: A tool for temporally regulated gene activation/inactivation in the mouse
S Hayashi et al.
DEVELOPMENTAL BIOLOGY (2002)
Conditional mouse models of sporadic cancer
J Jonkers et al.
NATURE REVIEWS CANCER (2002)
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
EL Jackson et al.
GENES & DEVELOPMENT (2001)
Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer
J Jonkers et al.
NATURE GENETICS (2001)
Somatic activation of the K-ras oncogene causes early onset lung cancer in mice
L Johnson et al.
NATURE (2001)
A simple method for the rapid generation of recombinant adenovirus vectors
RD Anderson et al.
GENE THERAPY (2000)
Share Paper
